Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,427
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
for
Severe Aplastic Anemia (SAA),
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 4 - 70+
Code: NCT03520647
Phase2, Recruiting
Multi-site Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants and Verification of Measurement Precision of Liquid Quality Controls With the Perosphere Technologies' PoC Coagulometer
for
Coagulation
Location: Danbury CT, White Plains NY, Rockville MD,
Sponsor: Sciema UG
Sex: All
Age: 18 - 70+
Code: NCT04868214
Recruiting
Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage
for
Intraventricular Hemorrhage of Prematurity
Location: Baltimore MD, St. Petersburg FL
Sponsor: Johns Hopkins University
Sex: All
Age: 0
Code: NCT05617833
Phase1, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
for
Glioblastoma Multiforme
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18 - 70+
Code: NCT05083754
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Norwich CT, White Plains NY, New York NY, Belleville NJ,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
for
Long Haul COVID, Postural Orthostatic Tachycardia Syndrome
Location: Bethesda MD
Sponsor: Uniformed Services University of the Health Sciences
Sex: All
Age: 18 - 70+
Code: NCT05481177
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Saint John, South Portland ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase3, Recruiting
Blue Light Cystoscopy With Cysview® Registry
for
Bladder Cancer
Location: New York NY, Baltimore MD, Washington D.C. DC,
Sponsor: Photocure
Sex: All
Age: 18+
Code: NCT02660645
Recruiting
ATLAS (AltaValve) Pivotal Trial
for
Mitral Regurgitation, Mitral Insufficiency,
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: 4C Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06465745
Recruiting
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
for
Lung Transplant
Location: Philadelphia PA, Baltimore MD, Columbus OH,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05547698
Recruiting
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
for
Glaucoma
Location: Boston MA, Baltimore MD, Chapel Hill NC, Miami FL,
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT05924477
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Westbrook ME, Worcester MA, Hartford CT, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
for
Neurofibromatosis Type 1
Location: New York NY, Philadelphia PA, Baltimore MD,